Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Matthias Zehner"'
Autor:
Meryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, Nareshkumar Poopalasingam, Susanne Detmer, Manuel Koch, Michael Korenkov, Sandro Halwe, Michael Klüver, Veronica Di Cristanziano, Hanna Janicki, Maike Schlotz, Johanna Worczinski, Birgit Gathof, Henning Gruell, Matthias Zehner, Stephan Becker, Kanika Vanshylla, Christoph Kreer, Florian Klein
Publikováno v:
iScience, Vol 25, Iss 3, Pp 103951- (2022)
Summary: Preexisting immunity against SARS-CoV-2 may have critical implications for our understanding of COVID-19 susceptibility and severity. The presence and clinical relevance of a preexisting B cell immunity remain to be fully elucidated. Here, w
Externí odkaz:
https://doaj.org/article/2404de6fd5954a088328929e1de3cfe8
Autor:
Sebastian J Theobald, Alexander Simonis, Theodoros Georgomanolis, Christoph Kreer, Matthias Zehner, Hannah S Eisfeld, Marie‐Christine Albert, Jason Chhen, Susanne Motameny, Florian Erger, Julia Fischer, Jakob J Malin, Jessica Gräb, Sandra Winter, Andromachi Pouikli, Friederike David, Boris Böll, Philipp Koehler, Kanika Vanshylla, Henning Gruell, Isabelle Suárez, Michael Hallek, Gerd Fätkenheuer, Norma Jung, Oliver A Cornely, Clara Lehmann, Peter Tessarz, Janine Altmüller, Peter Nürnberg, Hamid Kashkar, Florian Klein, Manuel Koch, Jan Rybniker
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 8, Pp n/a-n/a (2021)
Abstract Innate immunity triggers responsible for viral control or hyperinflammation in COVID‐19 are largely unknown. Here we show that the SARS‐CoV‐2 spike protein (S‐protein) primes inflammasome formation and release of mature interleukin
Externí odkaz:
https://doaj.org/article/2445731f5efd43e7bf9dcd749ffcad99
Autor:
Sandro Halwe, Alexandra Kupke, Kanika Vanshylla, Falk Liberta, Henning Gruell, Matthias Zehner, Cornelius Rohde, Verena Krähling, Michelle Gellhorn Serra, Christoph Kreer, Michael Klüver, Lucie Sauerhering, Jörg Schmidt, Zheng Cai, Fei Han, David Young, Guangwei Yang, Marek Widera, Manuel Koch, Anke Werner, Lennart Kämper, Nico Becker, Michael S. Marlow, Markus Eickmann, Sandra Ciesek, Felix Schiele, Florian Klein, Stephan Becker
Publikováno v:
Viruses, Vol 13, Iss 8, p 1498 (2021)
Despite the recent availability of vaccines against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), there is an urgent need for specific anti-SARS-CoV-2 drugs. Monoclonal neutralizing antibodies are an important drug class in the g
Externí odkaz:
https://doaj.org/article/a952a8244dfc4b74bafbb2519784edf5
Autor:
Michael Korenkov, Matthias Zehner, Hadas Cohen-Dvashi, Aliza Borenstein-Katz, Lisa Kottege, Hanna Janicki, Kanika Vanshylla, Timm Weber, Henning Gruell, Manuel Koch, Ron Diskin, Christoph Kreer, Florian Klein
SUMMARYSomatic hypermutation (SHM) drives affinity maturation and continues over months in SARS-CoV-2 neutralizing antibodies. Yet, several potent SARS-CoV-2 antibodies carry no or only few mutations, leaving the question of how ongoing SHM affects n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2dd49e1b27917e34bc1d395ad127da3
https://doi.org/10.1101/2023.05.09.539943
https://doi.org/10.1101/2023.05.09.539943
Autor:
Henning Gruell, Kanika Vanshylla, Michael Korenkov, Pinkus Tober-Lau, Matthias Zehner, Friederike Münn, Hanna Janicki, Max Augustin, Philipp Schommers, Leif Erik Sander, Florian Kurth, Christoph Kreer, Florian Klein
SARS-CoV-2 neutralizing antibodies play a critical role in prevention and treatment of COVID-19 but are challenged by viral evolution and antibody evasion, exemplified by the highly resistant Omicron BA.1 sublineage.1–12 Importantly, the recently i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9143827d7bd53b756107a4ed4bbedd2d
https://doi.org/10.1101/2022.04.06.487257
https://doi.org/10.1101/2022.04.06.487257
Autor:
Henning Gruell, Kanika Vanshylla, Michael Korenkov, Pinkus Tober-Lau, Matthias Zehner, Friederike Münn, Hanna Janicki, Max Augustin, Philipp Schommers, Leif Erik Sander, Florian Kurth, Christoph Kreer, Florian Klein
Publikováno v:
Cell hostmicrobe. 30(9)
SARS-CoV-2 neutralizing antibodies play a critical role in COVID-19 prevention and treatment but are challenged by viral evolution and the emergence of novel escape variants. Importantly, the recently identified Omicron sublineages BA.2.12.1 and BA.4
Autor:
Artem Ashurov, Timm Weber, Alexandra Kupke, Hanna Janicki, Nico Pfeifer, Reinhild Brinker, Hadas Cohen-Dvashi, Jan Mathis Eckert, Simone Lederer, Meryem S. Ercanoglu, Cornelius Rohde, Stephan Becker, Veronica Di Cristanziano, Maria J G T Vehreschild, Clemens M. Wendtner, Manuel Koch, Florian Klein, Sandro Halwe, Christoph Kreer, Philipp Schommers, Matthias Zehner, Kanika Vanshylla, Verena Krähling, Henning Gruell, M. Korenkov, Lutz Gieselmann, Timo Wolf, Ron Diskin
Publikováno v:
Cell
Summary The SARS-CoV-2 pandemic has unprecedented implications for public health, social life, and the world economy. Because approved drugs and vaccines are limited or not available, new options for COVID-19 treatment and prevention are in high dema
Autor:
Meryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, Nareshkumar Poopalasingam, Susanne Detmer, Manuel Koch, Michael Korenkov, Sandro Halwe, Michael Klüver, Veronica Di Cristanziano, Hanna Janicki, Maike Schlotz, Johanna Worczinski, Birgit Gathof, Henning Gruell, Matthias Zehner, Stephan Becker, Kanika Vanshylla, Christoph Kreer, Florian Klein
Publikováno v:
iScience. 25(3)
Preexisting immunity against SARS-CoV-2 may have critical implications for our understanding of COVID-19 susceptibility and severity. The presence and clinical relevance of a preexisting B cell immunity remain to be fully elucidated. Here, we provide
Autor:
Meryem S. Ercanoglu, Veronica Di Cristanziano, M. Korenkov, Ursula Hanna Janicki, Nareshkumar Poopalasingam, Sabrina Daehling, Stephan Becker, Birgit Gathof, Christoph Kreer, Manuel Koch, Henning Gruell, Kanika Vanshylla, Matthias Zehner, Sandro Halwe, Susanne Detmer, Lutz Gieselmann, Florian Klein, Michael Kluever, Maike Schlotz, Johanna Worczinski
SummaryPre-existing immunity against SARS-CoV-2 may have critical implications for our understanding of COVID-19 susceptibility and severity. Various studies recently provided evidence of pre-existing T cell immunity against SARS-CoV-2 in unexposed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f7da87a1812c85c040344198d53507d
https://doi.org/10.1101/2021.09.08.459398
https://doi.org/10.1101/2021.09.08.459398
Autor:
Philipp Schommers, Veronica Di Cristanziano, Kirsten Alexandra Eberhardt, Matthias Zehner, Gerd Fätkenheuer, Ricarda Stumpf, Max Augustin, Petra Mayer, Lutz Gieselmann, Carola Horn, Ralf Eggeling, Florian Klein, Felix Dewald, Nico Pfeifer, Meryem S. Ercanoglu, Norma Jung, Maike Schlotz, Wibke Johannis, Susanne Salomon, Isabelle Suárez, Eva Heger, Franziska Kleipass, Clara Lehmann, Henning Gruell, Birgit Gathof, Kanika Vanshylla
Publikováno v:
Cell Host & Microbe
Cell Host Microbe
Cell Host Microbe
Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-19 pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody dynamics over 10 months in 963 individuals who predominantly experienced mild COV